Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 11;16(1):e52076.
doi: 10.7759/cureus.52076. eCollection 2024 Jan.

Quantification of Chemotherapy Drug Wastage and Incurred Financial Loss in Paediatric Cancer Care: A Cross-Sectional Study at a Tertiary Care Public Hospital in India

Shweta Ghate  1 , Swati Patil  2   1 , Neha Kadhe  1 , Rutuja Fulsoundar  1 , Sudhir Pawar  1
Affiliations

Quantification of Chemotherapy Drug Wastage and Incurred Financial Loss in Paediatric Cancer Care: A Cross-Sectional Study at a Tertiary Care Public Hospital in India

Shweta Ghate et al. Cureus. .

Abstract

Aim: The evolving chemotherapy landscape continually introduces effective agents, but escalating costs call for an evaluation of drug wastage and financial consequences to enhance resource utilization. This study seeks to estimate chemotherapy drug wastage and its economic loss in paediatric cancer care.

Methods: In this cross-sectional study of paediatric cancer patients receiving parenteral chemotherapy, we evaluated both the drug used and wasted during each administration. The monetary value of drug loss was calculated using the formula: Cost = Proportion of drug wasted X Cost of drug vial.

Result: A total of 100 paediatric cancer patients who received 140 parenteral drug administrations of 22 chemotherapy drugs were studied. The total amount of drug procured was 25,515 mg, out of which 5,004.9 mg were wasted. Wastage amounted to 19.61% of the procured drugs in varying proportions. The total estimated cost of chemotherapy stood at 110,143.1 INR (1,328.7 USD), with cost wastage accounting for 31,929.95 INR (385.19 USD), equivalent to 28.98% of the total expenditure. Notably, doxorubicin 112.2 mg (37.4%) exhibited the highest drug wastage, followed by cytarabine 280 mg (35%) and l-asparaginase 83,400 IU (26.9%), primarily prescribed for acute lymphocytic leukaemia. Cytarabine resulted in the highest financial loss. Dose rounding occurred in 22 cases (15.71%), while vial sharing was observed in only five cases (3.57%) during drug administrations. Methotrexate, doxorubicin, and cytarabine doses never matched the available vial sizes.

Conclusions: In resource-limited healthcare settings, implementing centre-specific measures, such as vial sharing and drug categorization, can reduce drug wastage and financial losses. Evaluating the viability of optimizing vial sizes and producing multidose vials is essential.

Keywords: cost; drug vial optimisation; health economics; rounding of doses; vial sharing; vial size.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Digumarti R, Koyyala VP. Vol. 75757. London, UK: IntechOpen; 2022. Patterns of Care of Childhood Cancers in India.
    1. Pediatric cancers in India: the forgotten disease. Radhakrishnan V, Howard S, Lam C. Cancer Res Stat Treat. 2021;4:6–7.
    1. Drug pricing: a major barrier to access to cancer care in India. Cancer Research, Statistics, and Treatment. Radhakrishnan V. Cancer Res Stat Treat. 2021;4:195–197.
    1. Financial audit of wastage of anticancer drugs: pilot study from a tertiary care center in India. D'Souza VR, Palatty PL, George T, Adnan M, Rao S, Baliga MS. Indian J Cancer. 2019;56:146–150. - PubMed
    1. "Financial audit of wastage of anticancer drugs: pilot study from a tertiary care center of India": a commentary. Erenay FS, Horton S. Indian J Cancer. 2019;56:99–100. - PubMed

LinkOut - more resources